Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trial-Reference-Cited by-同舟云学术

Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trial

Published:2020-10 Issue:10 Volume:21 Page:1341-1352
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Sargos Paul,Chabaud Sylvie,Latorzeff Igor,Magné Nicolas,Benyoucef Ahmed,Supiot Stéphane,Pasquier David,Abdiche Menouar Samir,Gilliot Olivier,Graff-Cailleaud Pierre,Silva Marlon,Bergerot Philippe,Baumann Pierre,Belkacemi Yazid,Azria David,Brihoum Meryem,Soulié Michel,Richaud Pierre

Publisher

Elsevier BV

Subject

Oncology

Reference33 articles.

1. 10-Year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer;Hamdy;N Engl J Med,2016

2. Adjuvant radiotherapy versus wait-and-see after radical prostatectomy: 10-year follow-up of the ARO 96-02/AUO AP 09/95 trial;Wiegel;Eur Urol,2014

3. Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial;Thompson;J Urol,2009

4. Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911);Bolla;Lancet,2012

5. The effect of salvage radiotherapy and its timing on the health-related quality of life of prostate cancer patients;van Stam;Eur Urol,2016

Cited by 223 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Socioeconomic Barriers to Receiving Early Salvage Radiotherapy for Locally Advanced Prostate Adenocarcinoma: A Retrospective Single-Center Study;Cureus;2024-09-08

2. Risk Stratification of Patients with Recurrence After Primary Treatment for Prostate Cancer: A Systematic Review;European Urology;2024-09

3. Prognostic significance of a negative PSMA PET/CT in biochemical recurrence of prostate cancer;Cancer Imaging;2024-08-30

4. Usefulness of Tissue Biomarkers versus Prostate-Specific Membrane Antigen-Positron Emission Tomography for Prostate Cancer Biochemical Recurrence after Radical Prostatectomy;Cancers;2024-08-19

5. Delayed definitive management of localized prostate cancer: what do we know?;Prostate Cancer and Prostatic Diseases;2024-08-11